Fructooligosaccharides attenuate non-alcoholic fatty liver disease by remodeling gut microbiota and association with lipid metabolism.
Biomed Pharmacother
; 159: 114300, 2023 Mar.
Article
in En
| MEDLINE
| ID: mdl-36696803
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Non-alcoholic Fatty Liver Disease
/
Gastrointestinal Microbiome
Type of study:
Risk_factors_studies
Language:
En
Journal:
Biomed Pharmacother
Year:
2023
Type:
Article